Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Cardiovascular risk REduction Study: Supported by an Integrated Dietary Approach
ISRCTN ISRCTN92382106
ClinicalTrials.gov identifier
Public title Cardiovascular risk REduction Study: Supported by an Integrated Dietary Approach
Scientific title The effectiveness of an integrated cardioprotective dietary intervention compared with an average UK diet in reducing cardiovascular disease risk factors in older men and women aged 40 - 70 years
Acronym CRESSIDA
Serial number at source N02047
Study hypothesis An integrated dietary approach using a cardioprotective diet will significantly reduce cardiovascular disease (CVD) risk factors compared to the average UK diet.
Lay summary
Ethics approval St. Thomas' Hospital Research Ethics Committee approved the study in April 2010 (ref: 10/H0802/24)
Study design Randomised parallel design single-centre controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular disease
Participants - inclusion criteria Healthy men and women, aged 40 - 70 years
Participants - exclusion criteria 1. A reported history of angina, myocardial infarction, peripheral vascular disease, congenital heart disease or stroke
2. Asymptomatic atrial fibrillation
3. Type 1 or type 2 diabetes mellitus (fasting plasma glucose greater than 7 mmol/L)
4. Seated blood pressure greater than 160/105 mmHg
5. Current use of medication for lowering blood cholesterol (statins) or blood pressure
6. Body mass index less than 18.5 and greater than 35 kg/m2
7. An overall risk of cardiovascular disease over the next ten years of greater than 20% assessed according to current NICE guidelines in combination with untreated high blood pressure or raised cholesterol
8. Clinical history of cancer (excluding basal cell carcinoma) in the past five years
9. Chronic renal, liver or inflammatory bowel disease
10. Current cigarette smoker (confirmed by urinary cotinine analysis)
11. History of substance abuse or alcoholism (previous weekly alcohol intake greater than 60 units/men or 50 units/women)
12. Current self-reported weekly alcohol intake not exceeding 21 units for women and 28 for men
13. Currently pregnant, planning pregnancy or having had a baby in the last 12 months
14. Unwilling to follow the protocol and/or give informed consent
15. Unwilling to refrain from use of dietary supplements
16. Unwilling to restrict consumption of oily fish
17. Weight change of greater than 3 kg in preceding 2 months
Anticipated start date 16/07/2010
Anticipated end date 30/06/2012
Status of trial Ongoing
Patient information material Can be found at http://www.medscinet.net/CRESSIDA
Target number of participants 196
Interventions This is a controlled dietary intervention trial comparing a cardioprotective diet (decreased salt and saturated fatty acids intake, and increased wholegrain cereals, fruit and vegetables and oily fish intake) with a control diet (average UK diet) for 3 months.
Primary outcome measure(s) A change in systolic blood pressure (BP) measured by ambulatory blood pressure, a change in endothelial function measured by flow-mediated dilation, and a change in total/high density lipoprotein (HDL) cholesterol ratio measured at baseline and 3 months.
Secondary outcome measure(s) 1. A change in arterial stiffness (pulse wave velocity and digital volume pulse), measured at baseline and 3 months
2. A change in insulin sensitivity (revised quantitative insulin sensitivity test [RQUICKI] and serum adiponectin), measured at baseline and 3 months
3. A change in C-reactive protein concentrations, measured at baseline and 3 months
Sources of funding Food Standards Agency (FSA) (UK) (ref: N02047)
Trial website http://www.medscinet.net/CRESSIDA/
Publications
Contact name Prof  Thomas  Sanders
  Address Nutritional Science Division
4th Floor, Franklin-Wilkins Building
150 Stamford Street
  City/town London
  Zip/Postcode SE1 9NH
  Country United Kingdom
  Tel +44 (0)20 7848 4273
  Fax +44 (0)20 7848 4171
  Email tom.sanders@kcl.ac.uk
Sponsor King's College London (KCL) (UK)
  Address Room 1.8, Hodgkin Building
Guy's Campus
  City/town London
  Zip/Postcode SE1 1UL
  Country United Kingdom
  Tel +44 (0)20 7848 6960
  Fax +44 (0)20 7848 6394
  Email keith.brennan@kcl.ac.uk
  Sponsor website: http://www.kcl.ac.uk
Date applied 04/08/2010
Last edited 11/10/2010
Date ISRCTN assigned 11/10/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central